SomnoMed Ltd (ASX: SOM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

SomnoMed Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $60.44 million
P/E Ratio 136.99
Dividend Yield 0.00%
Shares Outstanding 219.77 million
Earnings per share -0.012
Dividend per share N/A
Year To Date Return -64.40%
Earnings Yield 0.73%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • SomnoMed Ltd (ASX: SOM)
    Latest News

    a woman
    ⏸️ Investing

    Why these 4 ASX shares have started the week in the red

    The Wattle Health Australia Ltd (ASX:WHA) share price is one of four starting the week in the red. Here's why...

    Read more »

    a woman
    ⏸️ Investing

    6 shares you need to watch on Tuesday

    The Fisher & Paykel Healthcare (ASX:FPH) share price could receive some attention today

    Read more »

    a woman
    ⏸️ Investing

    8 shares you need to watch on Tuesday

    The Coca-Cola Amatil (ASX:CCL) share price could receive some unwanted attention again today

    Read more »

    a woman
    ⏸️ Investing

    Why the Somnomed Limited share price surged 11% today

    The Somnomed (ASX:SOM) share price hit a 52-week low on Friday

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares have started the week with solid gains

    The Iluka Resources Limited (ASX:ILU) share price is one of four starting the week with solid gains. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares have climbed higher today

    The Bellamy's Australia Ltd (ASX:BAL) share price is one of four defying the market and climbing higher today. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares have sunk like stones today

    The Santos Ltd (ASX:STO) share price is one of four sinking like stones today. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    S&P/ASX 200 finishes higher Wednesday: 9 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) ended higher on Wednesday with share price gains from a2 Milk Company Ltd (Australia) (ASX:A2M) and…

    Read more »

    a woman
    ⏸️ Investing

    Why the Somnomed Limited share price is cratering today

    Could Nanosonics Ltd (ASX:NAN) be a better bet than Somnomed Limited (ASX:SOM)?

    Read more »

    a woman
    ⏸️ Investing

    Why Somnomed Limited is among 4 shares falling today

    The market is rallying strongly today, but that hasn't been enough to help shares like Somnomed Limited (ASX:SOM).

    Read more »

    a woman
    ⏸️ Investing

    Why MesoBLAST limited is rocketing higher on FDA approval

    The Mesoblast limited (ASX:MSB) share price is responding to FDA recognition of its aGVHD drug.

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 shares are soaring higher today

    These four shares have started the week off on a very positive note.

    Read more »

    SOM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About SomnoMed Ltd

    SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep disordered breathing relieving conditions. The company was founded on March 16, 1987 and is headquartered in Sydney, Australia.

    SOM Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    09 Oct 2026 $0.28 $-0.01 -3.45% 25,722 $0.28 $0.28 $0.28
    08 Oct 2026 $0.29 $0.00 0.00% 100,011 $0.29 $0.29 $0.27
    02 Oct 2026 $0.29 $-0.03 -9.52% 62,956 $0.30 $0.30 $0.29
    01 Oct 2026 $0.32 $0.02 6.78% 41,269 $0.30 $0.32 $0.30
    30 Sep 2026 $0.30 $0.01 3.45% 29,998 $0.30 $0.30 $0.30
    29 Sep 2026 $0.29 $-0.02 -6.45% 23,625 $0.31 $0.31 $0.29
    28 Sep 2026 $0.31 $-0.01 -3.13% 43,757 $0.32 $0.32 $0.30
    25 Sep 2026 $0.32 $-0.01 -3.08% 84,605 $0.30 $0.32 $0.30
    23 Sep 2026 $0.33 $-0.01 -3.03% 103,916 $0.33 $0.33 $0.33
    21 Sep 2026 $0.33 $-0.01 -2.94% 58,800 $0.34 $0.34 $0.33
    18 Sep 2026 $0.34 $-0.01 -2.86% 80,799 $0.34 $0.34 $0.33
    16 Sep 2026 $0.35 $0.01 2.99% 31,106 $0.33 $0.35 $0.33
    15 Sep 2026 $0.34 $0.02 6.25% 288,564 $0.32 $0.34 $0.32
    14 Sep 2026 $0.32 $-0.01 -3.03% 224,575 $0.33 $0.34 $0.32

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    25 Aug 2026 Michael Gordon Expiry 185,000 $62,900
    Options expired.
    25 Aug 2026 Gaetano (Guy) Russo Expiry 370,000 $125,800
    Options expired.
    25 Aug 2026 Benjamin(Ben) Gisz Expiry 185,000 $62,900
    Options expired.
    25 Aug 2026 Karen Borg Expiry 185,000 $62,900
    Options expired.
    23 Jul 2026 Karen Borg Buy 575,000 $270,250
    Exercise of options.
    23 Jul 2026 Karen Borg Exercise 575,000 $270,250
    Exercise of options.
    04 Dec 2025 Amrita Blickstead Issued 1,700,000 $1,360,000
    Issue of options.
    04 Dec 2025 Karen Borg Issued 1,700,000 $1,360,000
    Issue of options.
    04 Dec 2025 Andrew Price Issued 300,000 $240,000
    Issue of options.
    04 Dec 2025 Benjamin(Ben) Gisz Issued 200,000 $160,000
    Issue of options. As per announcement
    04 Dec 2025 Gaetano (Guy) Russo Issued 600,000 $480,000
    Issue of options.
    04 Dec 2025 Michael Gordon Issued 200,000 $160,000
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael Gordon Non-Executive Director Aug 2020
    Mr Gordon is the Director of Koala Company Limited, a direct-to-consumer household goods retailer. He was previously the CFO of Rokt, a marketing technology company, and CFO of Different Technologies, a property technology company. Prior to these, Mr Gordon was the Group CFO and MD Group Services for Greenlit Brands Pty Limited. He started his career with PricewaterhouseCoopers, spending 10 years with them in South Africa, the United Kingdom and Australia specializing in the retail and pharmaceutical industries with experience in audit, taxation, and corporate finance. He is a Chairman of the Risk Committee.
    Mr Gaetano (Guy) Alfred Gerrard Russo Non-Executive ChairmanNon-Executive Director Aug 2020
    Mr Russo has a commercial and customer-focused background working in Australia and internationally. Previously, he has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of Ronald McDonald House Children's Charities. He has been a member of YPO since 2006, served as a member of the Business Council of Australia.
    Mr Andrew Price Non-Executive Director Jan 2025
    Mr Price is an executive in the medical device industry, has spent the last 25 years at ResMed in various senior roles. Prior to finishing his employment with ResMed, he was Chief Supply Chain Officer, leading all functions of the end-to-end supply chain including supplier management, manufacturing, logistics, distribution, quality assurance and regulatory affairs. Mr Price held roles at ResMed across product development, project management and business development globally. He is a member of the Risk Committee.
    Mr Benjamin(Ben) Gisz Non-Executive Director Oct 2024
    Mr Gisz is a director and member of the investment team at TDM Growth Partners, an investment firm specializing in long-term investments in high-growth companies globally. Ben has investment, corporate advisory and financial markets experience, including prior roles with Investec Group and Credit Suisse. Ben is a current Non-Executive Director at Australian pet supplies ecommerce business Pet Circle. He is a member of Risk Committee.
    Ms Karen Borg Executive DirectorChief Executive Officer Feb 2024
    Ms Borg has held senior roles in FTSE 100-250 medical devices, technology, consumer products and government services organizations. She was most recently the Chief Executive Officer for Catholic Healthcare Ltd and prior to this was the CEO of Healthdirect and the inaugural CEO of Jobs for NSW. Ms Borg began her career in the fast-moving consumer goods sector and worked for Goodman Fielder, Nestle and Revlon in global business development and marketing in Eastern Europe and Asia Pacific. She is on the Board of Optiscan Ltd and KOPWA Aged Care Services and was previously on the Board of The North Foundation and Interim Chair of the Australian Vaccine Research Alliance.
    Mr Terence Anthony Flitcroft Company Secretary
    -
    Ye-Fei Guo Chief Financial Officer
    -
    Terence Anthony Flitcroft Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 98,499,293 44.94%
    J P Morgan Nominees Australia Pty Limited 29,473,058 13.45%
    Dottie Investments Pty Ltd 9,166,619 4.18%
    Howarth PAF Pty Ltd <The Howarth Foundation A/C> 5,415,675 2.47%
    Caroline House Superannuation Fund Pty Ltd <The Caroline House S/F A/C> 5,266,331 2.40%
    Ginga Pty Ltd <TG Klinger S/F A/C> 3,590,114 1.64%
    BNP Paribas Nominees Pty Ltd <Clearstream> 3,584,104 1.64%
    Timbina Pty Limited <Timbina Super Fund A/C> 2,696,297 1.23%
    Ginga Pty Ltd 2,434,216 1.11%
    Amrita Singh Blickstead 2,392,364 1.09%
    P Neustadt Holdings Pty Limited <Belgove Super Fund A/C> 2,353,628 1.07%
    Penn Nominees Pty Ltd <JB Parncutt Family Account> 2,131,386 0.97%
    Mr Gaetano Alfred Gerrard <Rusbev Super FD A/C> 2,055,220 0.94%
    Ginga Pty Ltd <TG Klinger S/F A/C> 1 2,000,000 0.91%
    Lion Nominees Pty Ltd <JB Parncutt Family Super Account> 1,990,099 0.91%
    Parncutt Family Foundation Pty Ltd < Pancutt Family Foundation Account> 1,739,800 0.79%
    Citicorp Nominees Pty Limited 1,685,781 0.77%
    Dinwoodie Investments Pty Ltd 1,628,164 0.74%
    Equity Plan Services Pty Ltd 1,597,307 0.73%
    UBS Nominees Pty Ltd 1,578,029 0.72%

    Profile

    since

    Note